Home › Stock analysis › BVS
Bioventus (BVS) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
What changed since yesterday
- Closed at $13.81, +2.30% vs the prior close of $13.50.
- Volume 295.60K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BVS rises 2.3% to $13.81. Closed at $13.81, +2.30% vs the prior close of $13.50. Day range $13.69–$13.91, opened at $13.73.
Last close$13.81+2.30%
Day range13.69–13.91
Open13.73
Volume295.60K
52-week range6.47–15.89
Avg volume (20d)415.41K
BVS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — BVS rises 2.3% to $13.81
- Closed at $13.81, +2.30% vs the prior close of $13.50. Day range $13.69–$13.91, opened at $13.73.
- Volume was 295.60K shares, 0.5x its 50-day average of 570.50K — lighter than usual.
- Price is +1.0% vs its 50-day average ($13.67) and +31.1% vs its 200-day average ($10.54).
- 52-week range $6.47–$15.89; today's close sits at 78% of that range, 13.1% below the 52-week high.
Oct 14, 2026 — BVS dips 0.4% to $13.50
- Closed at $13.50, -0.44% vs the prior close of $13.56. Day range $13.32–$13.62, opened at $13.46.
- Volume was 338.40K shares, 0.6x its 50-day average of 582.68K — lighter than usual.
- Price is -1.4% vs its 50-day average ($13.70) and +28.5% vs its 200-day average ($10.51).
- 52-week range $6.46–$15.89; today's close sits at 75% of that range, 15.1% below the 52-week high.
Oct 13, 2026 — BVS ends flat (+0.2%) to $13.56, 3 up days in a row
- Closed at $13.56, +0.22% vs the prior close of $13.53. Day range $13.31–$13.84, opened at $13.62.
- Volume was 335.60K shares, 0.6x its 50-day average of 598.64K — lighter than usual.
- Price is -1.0% vs its 50-day average ($13.70) and +29.4% vs its 200-day average ($10.48).
- 52-week range $6.46–$15.89; today's close sits at 75% of that range, 14.7% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 — BVS jumps 3.6% to $13.53
- Closed at $13.53, +3.56% vs the prior close of $13.06. Day range $12.98–$13.68, opened at $13.07.
- Volume was 444.60K shares, 0.7x its 50-day average of 605.23K.
- Price is -1.2% vs its 50-day average ($13.69) and +29.5% vs its 200-day average ($10.44).
- 52-week range $6.37–$15.89; today's close sits at 75% of that range, 14.9% below the 52-week high.
Oct 9, 2026 — BVS rises 3.0% to $13.06
- Closed at $13.06, +2.96% vs the prior close of $12.69. Day range $12.64–$13.11, opened at $12.82.
- Volume was 273.30K shares, 0.4x its 50-day average of 611.78K — lighter than usual.
- Price is -4.5% vs its 50-day average ($13.69) and +25.4% vs its 200-day average ($10.41).
- 52-week range $6.37–$15.89; today's close sits at 70% of that range, 17.8% below the 52-week high.
Oct 8, 2026 — BVS dips 0.6% to $12.69, 3 down days in a row
- Closed at $12.69, -0.63% vs the prior close of $12.77. Day range $12.52–$12.77, opened at $12.72.
- Volume was 385.60K shares, 0.6x its 50-day average of 620.24K.
- Price is -7.3% vs its 50-day average ($13.69) and +22.2% vs its 200-day average ($10.39).
- 52-week range $6.37–$15.89; today's close sits at 66% of that range, 20.2% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — BVS dips 2.5% to $12.77
- Closed at $12.77, -2.52% vs the prior close of $13.10. Day range $12.75–$13.36, opened at $13.00.
- Volume was 365.20K shares, 0.6x its 50-day average of 632.05K — lighter than usual.
- Price is -6.8% vs its 50-day average ($13.70) and +23.3% vs its 200-day average ($10.36).
- 52-week range $6.37–$15.89; today's close sits at 67% of that range, 19.7% below the 52-week high.
Oct 6, 2026 — BVS slides 3.1% to $13.10
- Closed at $13.10, -3.11% vs the prior close of $13.52. Day range $13.07–$13.62, opened at $13.50.
- Volume was 295.50K shares, 0.5x its 50-day average of 642.60K — lighter than usual.
- Price is -4.4% vs its 50-day average ($13.71) and +26.7% vs its 200-day average ($10.34).
- 52-week range $6.37–$15.89; today's close sits at 71% of that range, 17.6% below the 52-week high.
Oct 5, 2026 — BVS rises 3.0% to $13.52
- Closed at $13.52, +2.97% vs the prior close of $13.13. Day range $13.07–$13.58, opened at $13.13.
- Volume was 356.80K shares, 0.6x its 50-day average of 644.92K — lighter than usual.
- Price is -1.3% vs its 50-day average ($13.69) and +31.2% vs its 200-day average ($10.31).
- 52-week range $6.37–$15.89; today's close sits at 75% of that range, 14.9% below the 52-week high.
Oct 2, 2026 — BVS dips 2.4% to $13.13, 4 down days in a row
- Closed at $13.13, -2.38% vs the prior close of $13.45. Day range $13.02–$13.52, opened at $13.52.
- Volume was 362.40K shares, 0.6x its 50-day average of 645.50K — lighter than usual.
- Price is -3.9% vs its 50-day average ($13.66) and +27.7% vs its 200-day average ($10.28).
- 52-week range $6.37–$15.89; today's close sits at 71% of that range, 17.4% below the 52-week high.
- That makes 4 straight losses.
BVS latest news & SEC filings
Every SEC filing by or about BVS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 27, 2026:
- Revenue: $153.21M (prior year $147.66M) (+3.8% vs Jun 28, 2025)
- Net income: $33.44M (prior year $7.46M) (+348.3% vs Jun 28, 2025)
- Diluted EPS: $0.47 (prior year $0.11) (+327.3% vs Jun 28, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 8.01 — Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 27, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade BVS
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Mar 5, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.88% (largest 3.6%).
- Liquidity: about 415.41K shares (≈$5.74M) trade per day on average.
- 52-week position: $13.81 vs a range of $6.47–$15.89 (78% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 3 sales; latest: Michelle Mcmurry-Heath sold 12,000 shares on Mar 11, 2026.
- Latest filings: 10-Q Aug 5, 2026; 8-K Aug 5, 2026; 8-K Jun 4, 2026.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
BVS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 13.73 | 13.91 | 13.69 | 13.81 | 295.60K |
| Oct 14, 2026 | 13.46 | 13.62 | 13.32 | 13.50 | 338.40K |
| Oct 13, 2026 | 13.62 | 13.84 | 13.31 | 13.56 | 335.60K |
| Oct 12, 2026 | 13.07 | 13.68 | 12.98 | 13.53 | 444.60K |
| Oct 9, 2026 | 12.82 | 13.11 | 12.64 | 13.06 | 273.30K |
| Oct 8, 2026 | 12.72 | 12.77 | 12.52 | 12.69 | 385.60K |
| Oct 7, 2026 | 13.00 | 13.36 | 12.75 | 12.77 | 365.20K |
| Oct 6, 2026 | 13.50 | 13.62 | 13.07 | 13.10 | 295.50K |
| Oct 5, 2026 | 13.13 | 13.58 | 13.07 | 13.52 | 356.80K |
| Oct 2, 2026 | 13.52 | 13.52 | 13.02 | 13.13 | 362.40K |
| Oct 1, 2026 | 13.68 | 13.79 | 13.39 | 13.45 | 509.30K |
| Sep 30, 2026 | 14.01 | 14.01 | 13.57 | 13.63 | 461.10K |
| Sep 29, 2026 | 13.95 | 14.15 | 13.77 | 14.00 | 449.10K |
| Sep 28, 2026 | 13.81 | 14.10 | 13.64 | 14.02 | 588.70K |
| Sep 25, 2026 | 13.56 | 13.94 | 13.42 | 13.81 | 455.40K |
| Sep 24, 2026 | 13.64 | 13.64 | 13.36 | 13.52 | 331.30K |
| Sep 23, 2026 | 13.56 | 13.64 | 13.21 | 13.61 | 329.60K |
| Sep 22, 2026 | 13.38 | 13.67 | 13.35 | 13.65 | 429.40K |
| Sep 21, 2026 | 13.04 | 13.47 | 12.76 | 13.31 | 473.10K |
| Sep 18, 2026 | 12.49 | 12.99 | 12.34 | 12.91 | 828.20K |
About Bioventus
Bioventus (BVS) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in DURHAM, NC. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1665988.
BVS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| John A. Bartholdson | Director | Jun 4, 2026 |
| Pat Beyer | Director | Jun 4, 2026 |
| Robert E Claypoole | President and CEO | Mar 17, 2026 |
| Philip G. Cowdy | Director | Jun 4, 2026 |
| Ajay Dhankhar | Director | Nov 25, 2025 |
| William A Hawkins | Director | Jun 4, 2026 |
| Mary Kay Ladone | Director | Jun 4, 2026 |
| Michelle Mcmurry-Heath | Director | Jun 4, 2026 |
| Guido J Neels | Director | Jun 4, 2026 |
| Guy P Nohra | Director | Jun 4, 2026 |
| Susan M Stalnecker | Director | Jun 4, 2026 |
| Martin P Sutter | Director | Jun 4, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Katrina J Church | SVP & Chief Compliance Officer | Apr 14, 2026 |
| Robert E Claypoole | President and CEO | Mar 17, 2026 |
| Anthony D'Adamio | SVP & General Counsel | Apr 14, 2026 |
| Mark Leonard Singleton | SVP & CFO | Apr 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 11, 2026 | Michelle Mcmurry-Heath | Sale | 12,000 | $8.79 |
| Dec 4, 2025 | Guy P Nohra | Sale | 10,000 | $7.57 |
| Nov 7, 2025 | Michelle Mcmurry-Heath | Sale | 17,701 | $7.42 |
BVS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $568.09M | $22.73M | 0.33 | $74.67M |
| Dec 31, 2024 | $573.28M | $-36.12M | -0.56 | $38.80M |
| Dec 31, 2023 | $512.35M | $-156.23M | -2.49 | $15.34M |
| Dec 31, 2022 | $512.12M | $-158.70M | -2.59 | $-13.54M |
| Dec 31, 2021 | $430.90M | $19.38M | -0.15 | $22.99M |
Latest balance sheet: total assets $673.35M, total liabilities $395.93M, cash $29.46M (as of Jun 27, 2026).
BVS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $15.26 |
| May 6, 2026 | 8-K Item 2.02 (results) | $10.92 |
| Mar 5, 2026 | 8-K Item 2.02 (results) | $9.10 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $7.55 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $7.29 |
| May 6, 2025 | 8-K Item 2.02 (results) | $6.20 |
| Mar 11, 2025 | 8-K Item 2.02 (results) | $10.80 |
| Nov 5, 2024 | 8-K Item 2.02 (results) | $11.48 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Mar 12, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on BVS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.